Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.17 CAD -2.45% Market Closed
Market Cap: 4.1B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Relative Value

The Relative Value of one BHC stock under the Base Case scenario is 108.65 CAD. Compared to the current market price of 11.17 CAD, Bausch Health Companies Inc is Undervalued by 90%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BHC Relative Value
Base Case
108.65 CAD
Undervaluation 90%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
60
vs Industry
87
Median 3Y
0.4
Median 5Y
0.6
Industry
2.5
Forward
0.3
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-8
Industry
21.9
Forward
2.1
vs History
68
vs Industry
48
Median 3Y
2.4
Median 5Y
4.4
Industry
16.5
vs History
15
vs Industry
35
Median 3Y
-1.2
Median 5Y
1.2
Industry
23.6
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3.1
Industry
2.1
vs History
93
vs Industry
41
Median 3Y
2.8
Median 5Y
3.3
Industry
2.6
Forward
2.4
vs History
93
vs Industry
51
Median 3Y
3.9
Median 5Y
4.5
Industry
5.2
vs History
90
vs Industry
38
Median 3Y
8.4
Median 5Y
8.6
Industry
13.3
Forward
7
vs History
92
vs Industry
30
Median 3Y
16
Median 5Y
19.1
Industry
16.6
Forward
8.5
vs History
76
vs Industry
21
Median 3Y
18.1
Median 5Y
21.4
Industry
15.6
vs History
71
vs Industry
15
Median 3Y
25.1
Median 5Y
27.2
Industry
19.1
vs History
53
vs Industry
60
Median 3Y
0.9
Median 5Y
1
Industry
1.9

Multiples Across Competitors

BHC Competitors Multiples
Bausch Health Companies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Bausch Health Companies Inc
TSX:BHC
4.1B CAD 0.3 -16.5 7.7 13.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CA
Bausch Health Companies Inc
TSX:BHC
Average P/E: 32.4
Negative Multiple: -16.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top